(Q41201828)

English

Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression

scientific article published on 19 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 September 2017

Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression (English)

1 reference

Europe PubMed Central

28 September 2017

0 references

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Meimei Bu

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Yizhen Shen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Shizhi An

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Rongqin Qi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Joanna A Sanderson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Yan Cai

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

19 October 2015

1 reference

Europe PubMed Central

28 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

37

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

3949-3956

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482613%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

https://scigraph.springernature.com/pub.10.1007/s13277-015-4237-x

0 references

An international assessment of ovarian cancer incidence and mortality.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Cancer survival in five continents: a worldwide population-based study (CONCORD).

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Regulatory T cells, tumour immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Tregs and rethinking cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

How regulatory T cells work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Tim-3, a negative regulator of anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Regulatory T cells contribute to the recovery of acute lung injury by upregulating Tim-3.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Mechanisms of foxp3+ T regulatory cell-mediated suppression

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4237-X

21 January 2018

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26482613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/26482613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FOXP3+ regulatory T cells in the human immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/26482613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41201828&oldid=2094251039"